aktiv8 turns a verified, biotech-first database — pipelines, products, catalysts, trials, funding, and live signals — into closed deals: surfacing the opportunity, handing you the verified email, drafting the outreach with AI, and tracking it to close.
Powered by Hakase.
Whether you're partnering an asset, investing in a company, winning a CRO client, advising on a mandate, or scouting an acquisition — deals worth hundreds of millions turn on timing. Yet the intelligence to act lives across expensive databases, ClinicalTrials.gov, EDGAR, FDA calendars, and press releases. Teams spend hours assembling a view that's stale the moment it's done, and end up reacting to deals they read about in the news.
aktiv8 replaces that patchwork with one real-time workspace — for BD and corporate development, VC and crossover investors, CROs and CDMOs, and the banks and advisors who serve them.
Every company, pipeline, asset, catalyst, trial, funding round, investor, and signal — in a single, continuously-refreshed view. Every source timestamped.
Hakase routes every question to the best model, grounds every answer in real data, and verifies high-stakes matches with a second model. Tuned for biotech BD — not a general-purpose chatbot.
From a PDUFA date to a personalised, signal-aware BD email — without copying between tabs or leaving the page.
Finding the company is the easy part. aktiv8 gives you the verified email to reach the right decision-maker, drafts a personalised, signal-aware message with AI, and tracks every follow-up like a CRM — all from one platform.
Hakase continuously pulls catalysts, trial updates, funding rounds, and press — matched to companies the moment they happen.
Every signal resolves to a full company profile — pipeline, funding, catalysts, and an AI-identified BD angle. Know why this company, why now.
Email-verified decision-maker contacts, plus a personalised signal-aware draft from Hakase. Tone controls. One click to send.
Every outreach is logged. Move deals through stages, assign owners, set next actions. Opportunities don't go cold.
A multi-model orchestration layer. A supervisor routes each task — match, report, question — to the right model, with automatic fallback for resilience.
The best model for each task, routed by a supervisor — with automatic fallback if any provider degrades.
Every output is built strictly from verified corpus facts. Fabricated figures are stripped before you see them.
High-stakes outputs like deal matches are generated by one model and stress-tested by another.
Every report and match becomes proprietary training data. The engine sharpens over time — on our data, never yours.
AI matchmaking scores in- and out-licensing fit across the corpus and proposes the deal archetype.
Map investor mandates, portfolios, and the right way in — then reach the decision-maker.
A live FDA/PDUFA calendar with AI-flagged BD angles on every event.
Investment-grade company, investor, and catalyst reports generated on demand.
Verified emails plus signal-aware, tone-controlled drafts — sent from the platform, no exporting.
A built-in CRM logs every outreach, stage, and next action. Promote any signal to a deal in one click.
A natural-language analyst across your entire corpus, with cited answers and sources.
Find partners, track competitors, prep meetings.
Screen companies, monitor catalysts, time deals.
Find emerging clients before they issue an RFP.
Profile companies and investors fast for mandates.
Track acquisition targets and pipeline gaps.
| Without aktiv8 | With aktiv8 |
|---|---|
| Multiple expensive databases | One workspace |
| Hours of manual research | One-click AI reports |
| Spot deals in the news | Spot deals first |
| Records, but no contact or no email | Verified emails — reach decision-makers directly |
| Export, switch tools, write from scratch | AI-drafted, signal-aware email in one click |
| No memory of your outreach | Built-in CRM tracks every follow-up to close |
| Static, stale data | Live and timestamped |
See aktiv8 on your own market in a 30-minute walkthrough.
Book a demo